Clinical Trial Update: mFOLFIRINOX as First-Line Chemotherapy in Treating Chinese Patients With Metastatic Pancreatic Cancer [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating mFOLFIRINOX as first-line chemotherapy in Chinese patients with metastatic pancreatic cancer has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Cancer

Drugs mentioned

• mFOLFIRINOX

Snippet

Sponsor: Yuhong Li | Conditions: Metastatic Pancreatic Cancer | Phase 2 | Status: COMPLETED